FRESENIUS SE & CO. KGAA - DE0005785604 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
39
1
40
41,53 EUR
|
-0,9776% |
15.05.2025 08:16
|
241,00 |
41,52 |
41,70 |
240,00 |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
0
0
0
|
Fresenius SE & Co. KGaA
Else-Kröner-Strasse 1
61352, Bad Homburg, DE
|
| Phone |
+49-6172-608-0 |
| Fax |
+49-6172-608-2628 |
| Email |
pr-fre@fresenius.com |
| Internet |
http://www.fresenius.de
|
| IR Contact/PR Contact |
Frau Bechtold/Herr Oliver Heieck |
| Symbol |
FRE |
| End of financial year |
31.12.2025 |
| Issued capital |
23.526.409.490,00 EUR |
/IBT-BA-HP/WEB-INF/snippets/root/company/contact.jsp
50
1
51
| Freefloat |
56,66% |
| Else Kröner-Fresenius-Stiftung |
26,96% |
| Fidelity Management & Research Co. LLC |
3,06% |
| Harris Associates LP |
2,99% |
| The Vanguard Group, Inc. |
2,60% |
| DWS Investment GmbH |
1,66% |
| BlackRock Fund Advisors |
1,57% |
| Norges Bank Investment Management |
1,54% |
| Amundi Asset Management SASU (Investment Management) |
1,08% |
| Eleva Capital SAS |
0,95% |
| Geode Capital Management LLC |
0,94% |
/IBT-BA-HP/WEB-INF/snippets/root/company/shareholders.jsp
46
0
46
| Michael Sen |
Chairman of Managing Board |
| Sara Lisa Hennicken |
Member of Executive Committee |
| Robert Möller |
Member of Executive Committee |
| Pierluigi Antonelli |
Member of Executive Committee |
| Dr. Michael Moser |
Member of Executive Committee |
| Wolfgang Kirsch |
Chairman of Supervisory Board |
| Holger Michel |
Member of Supervisory Board |
| Michael Diekmann |
Member of Supervisory Board |
| Oscar Romero de Paco |
Member of Supervisory Board |
| Susanne Zeidler |
Member of Supervisory Board |
| Grit Genster |
Member of Supervisory Board |
| Frauke Lehmann |
Member of Supervisory Board |
| Bernd Behlert |
Member of Supervisory Board |
| Alberto Fuentelsaz Franganillo |
Member of Supervisory Board |
| Dr. Michael Albrecht |
Member of Supervisory Board |
| Dr. Christoph Zindel |
Member of Supervisory Board |
| Dr. Iris Löw-Friedrich |
Member of Supervisory Board |
/IBT-BA-HP/WEB-INF/snippets/root/company/board.jsp
39
0
39
|
Activity Description
|
|
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
|
/IBT-BA-HP/WEB-INF/snippets/root/company/corporateactions.jsp
42
0
42
